All test packages
Prenatal Care

Geno NIPT 23

Screens chromosome number abnormalities across all 23 fetal chromosome pairs: 22 autosomal pairs and one sex chromosome pair.

1 testsTurnaround: 2–4 days

Screens chromosome number abnormalities across all 23 fetal chromosome pairs: 22 autosomal pairs and one sex chromosome pair.

NIPT is a screening test, not a diagnostic test. Please seek professional advice about eligibility and the meaning of your result.

Understanding NIPT screening

NIPT analyzes cell-free DNA in maternal blood, including DNA originating from the placenta, to assess the chance of selected fetal chromosome conditions. It uses a maternal blood sample without directly sampling the fetus. Packages differ in scope; choose after counseling, not simply by the number of items.

Package screening scope

23

All 23 chromosome pairs

What do these items mean?

All 23 chromosome pairs

Extends chromosome-number screening to the 22 autosomal pairs and the sex chromosome pair. “23 pairs” describes screening scope; it does not mean diagnosis of every genetic disease or structural chromosome change.

From blood sample to result counseling

Counseling & maternal blood sample
1

Counseling & maternal blood sample

Confirm gestational age, history and package suitability with your clinician before sampling.

DNA analysis
2

DNA analysis

The laboratory analyzes the sample within the chosen panel. Result turnaround: 2–4 days.

Results & follow-up counseling
3

Results & follow-up counseling

Your clinician explains the risk, the result’s limitations and any follow-up needed.

Results & important limitations

Low risk

Makes the screened conditions less likely but does not exclude them. Continue recommended prenatal care and ultrasound; NIPT does not assess every genetic condition or birth defect.

High risk

Does not diagnose an affected fetus. Seek genetic counseling and discuss diagnostic testing such as chorionic villus sampling or amniocentesis before important medical decisions.

No result / nonreportable result

Does not mean low risk. Your clinician will assess whether repeat sampling, ultrasound or diagnostic testing is appropriate.

Clinical references: SMFM #74 · ACOG

Included tests

Test name
Geno NIPT 23 non-invasive prenatal screening